Skip to main content

MoneyWorks4Me

Bacil Pharma informs about disclosure

26 Mar 2025 Evaluate
Bacil Pharma has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lal Lachmandas Hingorani.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1380.75
Cipla 1410.15
Lupin 2018.50
Zydus Lifesciences 1202.00
View more..